MARKET

AZN

AZN

AstraZeneca
NASDAQ

Real-time Quotes | Nasdaq Last Sale

56.97
-2.13
-3.60%
After Hours: 56.21 -0.76 -1.33% 17:20 01/24 EST
OPEN
57.73
PREV CLOSE
59.10
HIGH
57.77
LOW
55.50
VOLUME
10.42M
TURNOVER
--
52 WEEK HIGH
64.21
52 WEEK LOW
46.48
MARKET CAP
176.54B
P/E (TTM)
89.91
1D
5D
1M
3M
1Y
5Y
Analysis: Why Is It So Difficult To Obtain COVID-19 Monoclonal Antibody Treatments?
The demand for monoclonal antibody treatments to help in the recovery of COVID-19 patients has outpaced the supply, and this situation runs the risk of becoming more acute as federal regulators consider whether to limit the authorization of certain treatme...
Benzinga · 3h ago
Pfizer, AstraZeneca or J&J COVID-19 Shots Boost Sinovac Regime, Brazilian Study Shows
A third booster dose of a COVID-19 vaccine from either AstraZeneca Plc (NASDAQ: AZN), Pfizer Inc (NYSE: PFE) - BioNTech SE (NASDAQ:
Benzinga · 4h ago
AstraZeneca, Pfizer/ BioNTech or J&J shots found to boost effect of Sinovac COVID-19 vaccine
A booster dose of AstraZeneca (NASDAQ:AZN), Pfizer (NYSE:PFE)/ BioNTech (NASDAQ:BNTX), and Johnson & Johnson (NYSE:JNJ) vaccines led to a significant increase in COVID-19 antibody levels in those who initially received
Seekingalpha · 6h ago
UPDATE 1-Sinovac regimen gets strong boost from Pfizer, AstraZeneca or J&J COVID shots - study
A third booster dose of a COVID-19 vaccine made by either AstraZeneca, Pfizer-BioNTech or Johnson & Johnson increases antibody levels significantly in those who have previously received two doses of Sinovac's CoronaVac shot, a study has found. The study f...
Reuters · 7h ago
Ionis' Eplontersen Receives FDA Orphan Drug Status For Misfolded Protein Disorder
The 
Benzinga · 8h ago
Mixed COVID vaccine schedules offer stronger boost after Sinovac regimen - study
Mixed COVID vaccine schedules offer stronger boost after Sinovac regimen - study
reuters.com · 8h ago
Eplontersen granted Orphan Drug Designation in the US for transthyretin amyloidosis
WILMINGTON, Del., January 24, 2022--Eplontersen has been granted Orphan Drug Designation (ODD) in the US by the Food and Drug Administration (FDA) for the treatment of transthyretin-mediated amyloidosis, a systemic, progressive and fatal condition.
Business Wire · 10h ago
AstraZeneca Secures EMA Approval to Ramp Up COVID-19 Vaccine Manufacturing
MT Newswires · 12h ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of AZN. Analyze the recent business situations of AstraZeneca through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

28.57%Strong Buy
42.86%Buy
28.57%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average AZN stock price target is 67.68 with a high estimate of 73.00 and a low estimate of 60.00.
High73.00
Average67.68
Low60.00
Current 56.97
EPS
Actual
Estimate
0.200.410.610.82
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Institutional Holdings
Institutions: 1.12K
Institutional Holdings: 554.20M
% Owned: 17.88%
Shares Outstanding: 3.10B
TypeInstitutionsShares
Increased
303
45.90M
New
72
3.80M
Decreased
365
222.89M
Sold Out
322
183.78M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-1.23%
Pharmaceuticals & Medical Research
-0.63%
Key Executives
Non-Executive Chairman/Independent Director
Leif Johansson
Chief Executive Officer/Executive Director
Pascal Soriot
Chief Financial Officer/Executive Director
Aradhana Sarin
Chief Human Resource Officer/General Counsel
Jeffrey Pott
Executive Vice President/Chief Compliance Officer
Katarina Ageborg
Executive Vice President
Jose Baselga
Executive Vice President
Pam Cheng
Executive Vice President
Ruud Dobber
Executive Vice President
David Fredrickson
Executive Vice President
Menelas Pangalos
Executive Vice President
Iskra Reic
Executive Vice President
Leon Wang
Secretary
Adrian Kemp
Non-Executive Director
Euan Ashley
Non-Executive Director
Diana Layfield
Non-Executive Director
Tony Mok
Non-Executive Director
Andreas Rummelt
Non-Executive Director
Marcus Wallenberg
Non-Executive Independent Director
Philip Broadley
Non-Executive Independent Director
Michel Demare
Non-Executive Independent Director
Deborah Eldracher
Non-Executive Independent Director
Sherilyn McCoy
Non-Executive Independent Director
Nazneen Rahman
Declaration Date
Dividend Per Share
Ex-Div Date
--
Dividend USD 0.44
08/12/2021
02/21/2021
Dividend USD 0.93
02/25/2021
07/30/2020
Dividend USD 0.44
08/13/2020
--
Dividend USD 0.93
02/27/2020
--
Dividend USD 0.44
08/08/2019
--
Dividend USD 0.93
02/28/2019
07/26/2018
Dividend USD 0.44
08/09/2018
02/02/2018
Dividend USD 0.93
02/15/2018
07/28/2017
Dividend USD 0.44
08/09/2017
03/14/2017
Dividend USD 0.93
02/15/2017
09/08/2016
Dividend USD 0.44
08/10/2016
02/25/2016
Dividend USD 0.93
02/17/2016
07/30/2015
Dividend USD 0.44
08/12/2015
02/24/2015
Dividend USD 0.94
02/18/2015
07/31/2014
Dividend USD 0.9
08/13/2014
02/07/2014
Dividend USD 1.9
02/19/2014
08/01/2013
Dividend USD 0.9
08/14/2013
About AZN
AstraZeneca PLC (AstraZeneca) is a patient-focused biopharmaceutical company. The Company focuses on discovery and development, manufacturing and commercialization of prescription medicines, primarily for the treatment of diseases. The Company is focused on three main therapy areas: Oncology; Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Its pipeline forms a robust portfolio of investigational therapies in varied stages of clinical development. The Company has access to technologies, both internally and through its various collaborations. Its technologies include acoustic tube technology, advanced molecular imaging, cryo-electron microscopy (cryo-EM), functional genomics, multi-omics and AstraZeneca iLab. The Company’s acoustic tube technology helps it to handle and process millions of compounds for biological screening. Its AstraZeneca iLab is its prototype of an automated medicinal chemistry laboratory.

Webull offers kinds of AstraZeneca plc (ADR) stock information, including NASDAQ:AZN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AZN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AZN stock methods without spending real money on the virtual paper trading platform.